top of page
  • Extremely American

mRNA Inventor Dr. Malone: Insights into Bio-Medical War Games, UN Event 201 & Mounting Concerns

Rumble Overview November 13, 2021: “The unfortunate truth is that we're going to have to have many children die before people wake up here. That's what's going to happen. And that's what has the founders of the Unity Project just livid right now— is that we're rushing forward willy-nilly on damaging and killing children. And now they're gonna launch clinical trials in basically very young children— [ages] two to three, okay? And there will be childhood death. There will be childhood damage. And it seems that we're going to have to have that for people to “wake up,” to get through this brain fog they're all suffering.” (Dr. Robert Malone - November 12, 2021)

Dr. Robert Malone has 32 Years of Vaccine and Biopharmaceutical Research and Consulting Experience. He received his clinical research training UC Davis, UC San Diego, and Salk Institute Molecular Biology and Virology laboratories. Dr. Malone received his medical training at Northwestern University (MD) and Harvard University Medical School (Clinical Research Post Graduate), and in Pathology at UC Davis. He has almost 100 peer-reviewed publications, and has been an invited speaker at about 50 conferences. In 1989, research was performed that gave rise to the 10+ groundbreaking patents on mRNA vaccination, all with a priority date of March 3, 1989.

Malone first pioneered in-vitro RNA transfection and also in-vivo RNA transfection (in frog embryos, as well as mice).

His body of work resulted in over 10 patents and numerous publications, yielding about 7000 citations for this work. The paper was the first showing data for DNA and RNA side by side for in-vivo (the first paper for in-vivo DNA).

The NIH will hold a roundtable discussion on the ethics of vaccine mandates December 1, and it will feature Dr. Matthew Memoli, an NIH scientist from Dr. Anthony Fauci’s agency, who will be making the case against forced vaccination for COVID-19.


bottom of page